Samridhi Nallamshetty is a Rheumatology/Immunology physician. OpenAlex indexes 6 publications with 845 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2352 Bruce B Downs Blvd Ste 303
Wesley Chapel, FL 335449203
Telephone
813-388-6855Provider last certified this registry record 30 Aug 2021.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202526 payments
- Novartis Pharmaceuticals CorporationProgram year202511 payments
- GENZYME CORPORATIONProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
84.6%Corticosteroid35.7%Fluticasone Propionate62%Trelegy Ellipta20%Breo Ellipta19%Part D<11 patientsHistamine-1 Receptor Antagonist29.5%Azelastine Hcl69%Levocetirizine Dihydrochloride31%Part D<11 patients+ 3 more classes in this area
Anti-infectives
5.4%Penicillins with extended spectrum5.4%Amoxicillin100%Part D≥11 patientsMetabolism & gastrointestinal
5%Corticosteroid5%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prostaglandin E2 Exerts Homeostatic Regulation of Pulmonary Vascular Remodeling in Allergic Airway Inflammation
Journal of Allergy and Clinical Immunology
2010 - Prostaglandin E2 Exerts Homeostatic Regulation of Pulmonary Vascular Remodeling in Allergic Airway Inflammation
The Journal of Immunology
2009 - Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
Journal of Allergy and Clinical Immunology
2008 - Selective Deficiency of PGE2 Inhibits Goblet Cell Metaplasia in a Murine Model of Asthma
Journal of Allergy and Clinical Immunology
2008 - Successful Implementation of a Standardized Rapid Drug Desensitization Protocol for Chemotherapy and Rituximab in 413 Cases
Journal of Allergy and Clinical Immunology
2008
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”